Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP108647.RAbwwDNC_-Vjzy4lnqeVCOtPehls1lZk0fMCequhkb1-0130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108647.RAbwwDNC_-Vjzy4lnqeVCOtPehls1lZk0fMCequhkb1-0130_provenance.
• NP141065.RAb6gRxXBZ20Z0bItpJxYH5sqJTptzU4NwSAI4V6c_4Ao130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP141065.RAb6gRxXBZ20Z0bItpJxYH5sqJTptzU4NwSAI4V6c_4Ao130_provenance.
• NP141069.RASLv9e-bAqd16XfH9jLiH-KBUgvXvmZwLpb09Oq1gCj0130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP141069.RASLv9e-bAqd16XfH9jLiH-KBUgvXvmZwLpb09Oq1gCj0130_provenance.
• NP919826.RAzyYcj3VbMpzfXK3lJ-f0M_EspbfM9uG8MjID01Jbkhc130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP919826.RAzyYcj3VbMpzfXK3lJ-f0M_EspbfM9uG8MjID01Jbkhc130_provenance.
• NP107511.RAhI24lTn6mpreuBBL5E50ihiGeJJ-PXoUD9_pKGmTKjY130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107511.RAhI24lTn6mpreuBBL5E50ihiGeJJ-PXoUD9_pKGmTKjY130_provenance.
• NP107962.RAogcj3E3mXdPmLF1hqXPlM1N-RaAyUPjjA7alLLE4944130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107962.RAogcj3E3mXdPmLF1hqXPlM1N-RaAyUPjjA7alLLE4944130_provenance.
• NP115074.RAW2cADClMixPu7Bf9wzwDsfOUU_E7gYfZppBR39sxCeg130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115074.RAW2cADClMixPu7Bf9wzwDsfOUU_E7gYfZppBR39sxCeg130_provenance.
• NP115075.RAe8DlfVfWx9YbqdEWsR7B1o-uR5d7zB6Urz4oJwi9ls0130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115075.RAe8DlfVfWx9YbqdEWsR7B1o-uR5d7zB6Urz4oJwi9ls0130_provenance.
• NP115077.RAdO-U7ZMLhaiDkZYydRrcZxP3M1krQq_srQWEXop8y3k130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115077.RAdO-U7ZMLhaiDkZYydRrcZxP3M1krQq_srQWEXop8y3k130_provenance.
• NP115078.RASMI6C6z3NHg7ARVvoYii-wH7migjaSYRGZoMF4uhRkY130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115078.RASMI6C6z3NHg7ARVvoYii-wH7migjaSYRGZoMF4uhRkY130_provenance.
• NP115079.RAYOu1exHrqdj-9hPvBOmzHNS8GKzaqezPKBZhix8exG0130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115079.RAYOu1exHrqdj-9hPvBOmzHNS8GKzaqezPKBZhix8exG0130_provenance.
• NP115081.RAVim_9pYaiW60laZC9KbVhkMS6O2K8GFJ_W7UZPBMIU0130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115081.RAVim_9pYaiW60laZC9KbVhkMS6O2K8GFJ_W7UZPBMIU0130_provenance.
• NP90080.RAtrGmKYxrOMutbWIiqP0sUlksnIMZUIjXUAdTXkrLzks130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90080.RAtrGmKYxrOMutbWIiqP0sUlksnIMZUIjXUAdTXkrLzks130_provenance.
• NP90087.RAntfsiJGxoA2XNQj8bDaCyVyS-b3c6m2N8EkOV9Aoh-c130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90087.RAntfsiJGxoA2XNQj8bDaCyVyS-b3c6m2N8EkOV9Aoh-c130_provenance.
• NP115082.RADSpv1jD8OIaMp5lMaz_kHcBMSN7gKxof5qozVGCa2RI130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115082.RADSpv1jD8OIaMp5lMaz_kHcBMSN7gKxof5qozVGCa2RI130_provenance.
• NP115076.RAmYTcCjyirhTqEeFXZRKOFeMoCF1ilpcchtgIcc1fmWg130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115076.RAmYTcCjyirhTqEeFXZRKOFeMoCF1ilpcchtgIcc1fmWg130_provenance.
• NP115083.RAqitN6PsCDU4FUQydUdIRWBxpmrkDFcCDqhc_9IfZGbA130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115083.RAqitN6PsCDU4FUQydUdIRWBxpmrkDFcCDqhc_9IfZGbA130_provenance.
• NP97678.RA_vGy8cyE1qhMH3uzFxmYTU1QPUDsTIe0fICnoM8vCPA130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP97678.RA_vGy8cyE1qhMH3uzFxmYTU1QPUDsTIe0fICnoM8vCPA130_provenance.
• NP108246.RA_bNGPxugimvnCN7uJqxyVXd2w2FtLflWfqKhzrwcNE4130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP108246.RA_bNGPxugimvnCN7uJqxyVXd2w2FtLflWfqKhzrwcNE4130_provenance.
• NP134817.RA5fnh2EbDTIOXibeHBpCN16GOK5KcfGhuTtJ1TkXViJ0130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP134817.RA5fnh2EbDTIOXibeHBpCN16GOK5KcfGhuTtJ1TkXViJ0130_provenance.
• NP141300.RA5DJCbPQfIGDVPVFXbDf_Yjr6RxS-_9HbLZJmgBNUdr0130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP141300.RA5DJCbPQfIGDVPVFXbDf_Yjr6RxS-_9HbLZJmgBNUdr0130_provenance.
• NP107453.RAJC93-5jX9T_WCuc5DVZO21_lR-H0ziqvCJTPjkjS4ZM130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP107453.RAJC93-5jX9T_WCuc5DVZO21_lR-H0ziqvCJTPjkjS4ZM130_provenance.
• NP220097.RALNuj3iN15kazJvbKxc3QgADPA2etm9w_z01k4awA8_U130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP220097.RALNuj3iN15kazJvbKxc3QgADPA2etm9w_z01k4awA8_U130_provenance.
• NP115072.RAFBcvlbT6hUBY5wRVG0WwnZ2qaxkSJGagmz04tobF4RQ130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115072.RAFBcvlbT6hUBY5wRVG0WwnZ2qaxkSJGagmz04tobF4RQ130_provenance.
• NP115080.RAKvminDtcs3GC-i2SUaZZ6_Y8QwQh7CiABoBL_6Ua5EU130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115080.RAKvminDtcs3GC-i2SUaZZ6_Y8QwQh7CiABoBL_6Ua5EU130_provenance.
• NP115073.RA7Sqoz0AQ77zQTdXIs1pzmtqODXQMYi6EnCpqpmNcoM8130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP115073.RA7Sqoz0AQ77zQTdXIs1pzmtqODXQMYi6EnCpqpmNcoM8130_provenance.
• NP639739.RAyl9yEF0l_hXRLwVnfXSpdju2D8mOVFWB9y4CY82mZK4130_assertion description "[Haemostatic genetic variants, ABO blood group and bleeding risk during oral anticoagulant treatment after cerebral ischaemia of arterial origin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP639739.RAyl9yEF0l_hXRLwVnfXSpdju2D8mOVFWB9y4CY82mZK4130_provenance.